Seth Klarman: portfolio of Baupost Group
Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 13, 2018. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2018. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 11.1B USD
- Positions
- 31
- Share of the ten largest
- 79.1%
The ten largest positions Q2 2018
- Twenty First Centy Fox Inc 17.6%▲ +48.2%
- Synchrony Financial 8.8%unchanged
- Cheniere Energy Inc 8.3%▼ −31.5%
- Viasat Inc 8.1%▲ +0.5%
- Qorvo Inc 7.9%unchanged
- Allergan PLC 7.4%▲ +4.2%
- Pioneer Nat Res Co 6.8%unchanged
- Twenty First Centy Fox Inc 6.0%▲ +19.0%
- Antero Res Corp 5.1%unchanged
- Colony Cap Inc New 2.8%new
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2018
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Twenty First Centy Fox Inc | 17.6% | 39,415,829 | 2.0B USD | +48.2% increased | Q3 2015 12 quarters |
| SYF Synchrony Financial | 8.8% | 29,295,030 | 977.9M USD | unchanged | Q3 2016 8 quarters |
| Cheniere Energy Inc | 8.3% | 14,196,135 | 925.4M USD | −31.5% reduced | Q1 2014 18 quarters |
| Viasat Inc | 8.1% | 13,732,068 | 902.5M USD | +0.5% increased | Q2 2013 or earlier 21 quarters |
| Qorvo Inc | 7.9% | 11,000,000 | 881.9M USD | unchanged | Q1 2017 6 quarters |
| Allergan PLC | 7.4% | 4,950,000 | 825.3M USD | +4.2% increased | Q1 2016 10 quarters |
| Pioneer Nat Res Co | 6.8% | 4,000,000 | 757.0M USD | unchanged | Q3 2017 4 quarters |
| Twenty First Centy Fox Inc | 6.0% | 13,606,260 | 670.4M USD | +19.0% increased | Q3 2015 12 quarters |
| Antero Res Corp | 5.1% | 26,587,791 | 567.6M USD | unchanged | Q3 2014 16 quarters |
| Colony Cap Inc New | 2.8% | 49,687,370 | 310.0M USD | new | Q2 2018 1 quarter |
| T AT&T | 2.7% | 9,480,700 | 304.4M USD | new | Q2 2018 1 quarter |
| CAH Cardinal Health | 2.2% | 5,100,000 | 249.0M USD | unchanged | Q4 2016 7 quarters |
| Atara Biotherapeutics Inc | 2.1% | 6,254,632 | 229.9M USD | unchanged | Q4 2014 15 quarters |
| MCK McKesson Corporation | 2.0% | 1,627,700 | 217.1M USD | +0.7% increased | Q3 2017 4 quarters |
| Theravance Biopharma Inc | 1.9% | 9,309,168 | 211.1M USD | unchanged | Q2 2014 17 quarters |
| PCG PG&E Corporation | 1.7% | 4,500,000 | 191.5M USD | +42.9% increased | Q1 2018 2 quarters |
| COR Cencora | 1.4% | 1,873,565 | 159.8M USD | +42.2% increased | Q3 2017 4 quarters |
| Veritiv Corp | 1.4% | 3,824,385 | 152.4M USD | unchanged | Q3 2014 16 quarters |
| Tribune Media Co | 1.0% | 2,996,042 | 114.7M USD | new | Q2 2018 1 quarter |
| Keryx Biopharmaceuticals Inc | 0.9% | 25,791,678 | 97.0M USD | unchanged | Q1 2014 18 quarters |
| Sinclair Broadcast Group Inc | 0.7% | 2,571,302 | 82.7M USD | new | Q2 2018 1 quarter |
| AMC AMC Entertainment | 0.7% | 5,000,000 | 79.5M USD | unchanged | Q3 2017 4 quarters |
| Novagold Res Inc | 0.5% | 13,467,145 | 59.9M USD | unchanged | Q2 2013 or earlier 21 quarters |
| Gty Technology Holdings Inc | 0.4% | 4,400,000 | 45.9M USD | unchanged | Q4 2016 7 quarters |
| Paratek Pharmaceuticals Inc | 0.2% | 2,394,498 | 24.4M USD | unchanged | Q4 2014 15 quarters |
| Translate Bio Inc | 0.2% | 1,923,076 | 24.3M USD | new | Q2 2018 1 quarter |
| Saban Cap Acquisition Corp | 0.2% | 2,326,500 | 23.5M USD | unchanged | Q4 2016 7 quarters |
| Trilogy Metals Inc New | 0.2% | 13,050,758 | 23.2M USD | +23.1% increased | Q3 2016 8 quarters |
| Shire PLC | 0.2% | 98,932 | 16.7M USD | new | Q2 2018 1 quarter |
| Sentinel Energy Svcs Inc | 0.1% | 1,600,000 | 16.1M USD | unchanged | Q4 2017 3 quarters |
| Saban Cap Acquisition Corp | < 0.1% | 1,163,250 | 1.4M USD | unchanged | Q4 2016 7 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 2 positions in convertible bonds and bonds worth 336.2M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Tesla Inc principal 250.0M USD 306.3M USD
- Theravance Biopharma Inc principal 30.0M USD 30.0M USD
Breakdown by sector
- Financials 8.8%
- Health Care 5.6%
- Communication Services 3.5%
- Utilities 1.7%
- not in our coverage 80.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors